- Home
- CLDX vs BCRX Comparison
CLDX vs BCRX Comparison
Compare CLDX & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | BCRX |
|---|---|---|
| Founded | N/A | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CLDX | BCRX |
|---|---|---|
| Price | $33.03 | $9.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $46.60 | $20.82 |
| AVG Volume (30 Days) | 718.2K | ★ 3.5M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | $12,743,000.00 | ★ $25,186,000.00 |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | $12.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $19.52 | $6.00 |
| 52 Week High | $35.83 | $10.32 |
Technical Indicators
Market Signals| Indicator | CLDX | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 57.12 |
| Support Level | $28.51 | $7.97 |
| Resistance Level | $35.10 | $9.31 |
| Average True Range (ATR) | 1.15 | 0.33 |
| MACD | 0.47 | 0.09 |
| Stochastic Oscillator | 81.60 | 69.93 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.